529 - 540 of 7729 results
1 CME CREDIT

Polypharmacy and COVID-19

1.00 CME/MOC
1.00 AANP | 0.50 Pharmacology

COVID-19 has disproportionately impacted older adults through early high infection rates, social isolation, anxiety, depression and mortality. This session on polypharmacy and COVID-19 will improve how you treat the sequalae of COVID-19 in older adults and increase your awareness of polypharmacy. It will also provide the newest research on non-pharmacologic ways of treating the long-term effects of COVID-19 on older adults. Through interactive patient cases, Dr. Lee Lindquist will provide examples on how to safely and effectively manage the medications of your older adult patients during the COVID-19 pandemic. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 8/13/2020, and they are subject to change as new information is published.


PrimaryCareNOW: Recorded Live on August 13, 2020

2.00 CME/MOC
2.00 AANP | 1.25 Pharmacology


0.5 CME CREDIT

Join Dr. Frank Domino as he discusses an evidence-based approach to diagnosing and managing a condition frequently seen in primary care practice: shoulder pain. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on August 26th, 2020 and they are subject to change as new information is published.


0.5 CME CREDIT

In the fifteenth episode of Pri-Med’s weekly web series on COVID-19, faculty will revisit the data on chloroquine and hydroxychloroquine in the treatment of COVID-19 and will discuss the data on the effectiveness of hydroxychloroquine in post-exposure prophylaxis. Faculty will also review the recent data on proton pump inhibitors (PPI) and histamine2-receptor antagonists (H2RA) as they relate to COVID-19 risk, giving you the most current information on how to manage your patients taking these medications.


0.5 CME CREDIT

In the sixteenth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss how blood type may influence immune response and what impact it could have on risk of COVID-19 infection and severity. Faculty will also discuss the data on renin-angiotensin-aldosterone inhibitor use in COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 08/04/2020 and they are subject to change as new information is published.


computer drawing of a heart

Primary Care Heart Failure Learning Module

An Adaptive Learning Experience Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE Credit

Heart failure (HF) is a complex syndrome brought on by impairment of the structure or function of ventricular filling or blood ejection. These changes can significantly decrease quality of life, resulting in edema, dyspnea, and fatigue. The disease is widespread and progresses in severity, resulting in significant morbidity and mortality. This course is built on the latest HF guidelines and seeks to help learners better understand this prevalent, serious disease. Topics include pathophysiology, etiology, and epidemiology, morbidity and mortality, diagnosis through the use of biomarkers and other screening tools, impact of HF hospitalization, hospitalization care goals and team-based care.


Type 2 diabetes care today requires a multi-faceted approach comprising of new and improved medications, insulin treatments, and lifestyle modification strategies. Browse through our library of free type 2 diabetes CME/CE to stay current with best practices and evidence-based recommendations for diagnosing and treating patients with diabetes.